Low-density lipoprotein (LDL)-cholesterol, malondialdehyde-modified low-density lipoprotein (MDA-LDL), MDA-LDL/LDL-cholesterol in serum, and blood pressure are considered useful risk markers of cardiovascular diseases. This study aimed to examine whether a fermented milk containing Streptococcus thermophilus YIT 2001 (ST), which has high anti-oxidative activity, would benefit healthy and mildly hyper-LDL-cholesterolaemic adults via a randomised, double-blind, placebo-controlled trial. ST-fermented milk or non-fermented placebo milk (PC) was consumed once a day for 12 weeks by 29 and 30 subjects, respectively, with average serum LDL-cholesterol levels of about 140 mg/dl. Serum levels of LDL-cholesterol and MDA-LDL and blood pressure were analysed before (baseline) and after consumption. Comparisons of the responses between both groups were assessed using analysis of covariance (ANCOVA, with the baseline value as the covariate). ANCOVA demonstrated that the ST group had significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, systolic blood pressure (SBP), and diastolic blood pressure (DBP) compared with the PC group during the consumption period (P<0.05). Moreover, stratified analysis revealed that there were significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, SBP, and DBP in the ST group compared with the PC group during the consumption period in subjects who had above median (65 U/l) levels of oxidative stress marker MDA-LDL at baseline (P<0.05), but not in subjects with levels below the median. These findings suggest that daily consumption of ST-fermented milk may be beneficial in healthy or mildly hyper-LDL cholesterolaemic subjects through reductions in risk marker values of oxidative stress and/or cardiovascular diseases. The benefits were particularly remarkable in subjects who had higher levels of MDA-LDL.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Beltrán-Barrientos, L.M., Hernández-Mendoza, A., Torres-Llanez, M.J., González-Córdova, A.F. and Vallejo-Córdova, B., 2016. Invited review: fermented milk as antihypertensive functional food. Journal of Dairy Science 99: 4099-4110.
'Invited review: fermented milk as antihypertensive functional food ' () 99 Journal of Dairy Science : 4099 -4110.
Catapano, A.L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M., Durrington, P., Erdine, S., Halcox, J., Hobbs, R., Kjekshus, J., Filardi, P.P., Riccardi, G., Storey, R.F. and Wood, D., 2011. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217: 3-46.
'ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) ' () 217 Atherosclerosis : 3 -46.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (EP HBCA), 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment panel III). Journal of the American Medical Association 285: 2486-2497.
Fujihara, K., Suzuki, H., Sato, A., Kodama, S., Heianza, Y., Saito, K., Iwasaki, H., Kobayashi, K., Yatoh, S., Takahashi, A., Yahagi, N., Yagyu, H., Sone, H. and Shimano, H., 2015. Circulating malondialdehydemodified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes. Journal of Diabetes Research 2015: 507245.
'Circulating malondialdehydemodified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes ' () 2015 Journal of Diabetes Research : 507245.
Fujiyoshi, A., Ohkubo, T., Miura, K., Murakami, Y., Nagasawa, S., Okamura, T. and Ueshima, H. for the Observational Cohorts in Japan (EPOCH-JAPAN) Research Group, 2012. Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertension Research 35: 947-953.
'Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women ' () 35 Hypertension Research : 947 -953.
González, J., Valls, N., Brito, R. and Rodrigo, R., 2014. Essential hypertension and oxidative stress: new insights. World Journal of Cardiology 6: 353-366.
'Essential hypertension and oxidative stress: new insights ' () 6 World Journal of Cardiology : 353 -366.
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T. and Chayama, K., 2002. Endothelial function and oxidative stress in renovascular hypertension. New England Journal of Medicine 346: 1954-1962.
'Endothelial function and oxidative stress in renovascular hypertension ' () 346 New England Journal of Medicine : 1954 -1962.
Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. and Collen, D., 1998. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98: 1487-1494.
'Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease ' () 98 Circulation : 1487 -1494.
Ito, M., Oishi, K., Yoshida, Y., Okumura, T., Sato, T., Naito, E., Yokoi, W. and Sawada, H., 2015. Effects of lactic acid bacteria on low-density lipoprotein susceptibility to oxidation and aortic fatty lesion formation in hyperlipidemic hamsters. Beneficial Microbes 6: 287-293.
'Effects of lactic acid bacteria on low-density lipoprotein susceptibility to oxidation and aortic fatty lesion formation in hyperlipidemic hamsters ' () 6 Beneficial Microbes : 287 -293.
Kametsu, Y., Kitagawa, Y., Sekiyama, S. and Takagi, S., 2005. Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infraction. Tokai Journal of Experimental and Clinical Medicine 30: 171-176.
'Increase in plasma malondialdehyde-modified low-density lipoprotein in patients with atherothrombotic cerebral infraction ' () 30 Tokai Journal of Experimental and Clinical Medicine : 171 -176.
Khalesi, S., Sun, J., Buys, N. and Jayasinghe, R., 2014. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64: 897-903.
'Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials ' () 64 Hypertension : 897 -903.
Kotani, K., Maekawa, M., Kanno, T., Kondo, A., Toda, N. and Manabe, M., 1994. Distribution of immunoreactive malondialdehydemodified low-density lipoprotein in human serum. Biochimica et Biophysica Acta 1215: 121-125.
'Distribution of immunoreactive malondialdehydemodified low-density lipoprotein in human serum ' () 1215 Biochimica et Biophysica Acta : 121 -125.
Marteau, P., Minekus, M., Havenaar, R. and Huis in’t Veld, J.H.J., 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and effects of bile. Journal of Dairy Science 80: 1031-1037.
'Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and effects of bile ' () 80 Journal of Dairy Science : 1031 -1037.
Mater, D.D.G., Bretigny, L., Firmesse, O., Flores, M.-J., Mogenet, A., Bresson, J.-L. and Corthier, G., 2005. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiology Letters 250: 185-187.
'Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt ' () 250 FEMS Microbiology Letters : 185 -187.
Matsuo, Y., Tubo, T., Okumoto, Y., Ishibashi, K., Komukai, K., Tanimoto, T., Ino, Y., Kitabata, H., Hirata, K., Imanishi, T., Akagi, H. and Akasaka, T., 2013. Circulating malondialde-modified low-density lipoprotein levels are associated with the presence of thincap fibroatheromas determined by optical coherence tomography in coronary artery disease. European Heart Journal – Cardiovascular Imaging 14: 43-50.
'Circulating malondialde-modified low-density lipoprotein levels are associated with the presence of thincap fibroatheromas determined by optical coherence tomography in coronary artery disease ' () 14 European Heart Journal – Cardiovascular Imaging : 43 -50.
Mitsuoka, T., 2014. Development of functional foods. Bioscience of Microbiota, Food and Health 33: 117-128.
'Development of functional foods ' () 33 Bioscience of Microbiota, Food and Health : 117 -128.
Miura, K., Nakagawa, H., Ohashi, Y., Harada, A., Taguri, M., Kushiro, T., Takahashi, A., Nishinaga, M., Soejima, H. and Ueshima, H. for the Japan Arteriosclerosis Longitudinal Study (JALS) group, 2009. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Circulation 119: 1892-1898.
'Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies ' () 119 Circulation : 1892 -1898.
Miyazaki, K. and Matsuzaki, T., 2008. Health properties of milk fermented with Lactobacillus casei strain Shirota (LcS). In: Farnworth, E.R. (ed.) Handbook of fermented functional foods. CRC Press, Boca Raton, FL, USA, pp. 165-208.
'Health properties of milk fermented with Lactobacillus casei strain Shirota (LcS) ', in Handbook of fermented functional foods , () 165 -208.
Niki, E., 2011. Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. Journal of Clinical Biochemistry and Nutrition 48: 3-7.
'Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited ' () 48 Journal of Clinical Biochemistry and Nutrition : 3 -7.
Ono, M., Takabe, N., Oda, T., Nakagawa, R., Matsui, M., Sasai, T., Nagasawa, K., Honma, H., Kajiwara, T., Taneichi, H., Takahashi, Y., Takahashi, K. and Satoh, J., 2014. Association of coronary artery calcification with MDA-LDL/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes. Internal Medicine 53: 391-396.
'Association of coronary artery calcification with MDA-LDL/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes ' () 53 Internal Medicine : 391 -396.
Paravicini, T.M. and Touyz, R.M., 2006. Redox signaling in hypertension. Cardiovascular Research 71: 247-258.
'Redox signaling in hypertension ' () 71 Cardiovascular Research : 247 -258.
Shimizu, M., Hashiguchi, M., Shiga, T., Tamura, H. and Mochizuki, M., 2015. Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolaemic individuals. PLoS ONE 10: e0139795.
'Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolaemic individuals ' () 10 PLoS ONE : e0139795.
Steinberg, D., 1997. Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 272: 20963-20966.
'Low density lipoprotein oxidation and its pathobiological significance ' () 272 Journal of Biological Chemistry : 20963 -20966.
Tajika, K., Okamatsu, K., Takano, M., Inami, S., Yamamoto, M., Murakami, D., Kobayashi, N., Ohba, T., Hata, N., Seino, Y. and Mizuno, K., 2012. Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque. Circulation Journal 76: 2211-2217.
'Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque ' () 76 Circulation Journal : 2211 -2217.
Tanaga, K., Bujo, H., Inoue, M., Mikami, K., Kotani, K., Takahashi, K., Kanno, T. and Saito, Y., 2002. Increased circulating malondialdehydemodified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arteriosclerosis, Thrombosis, and Vascular Biology 22: 662-666.
'Increased circulating malondialdehydemodified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles ' () 22 Arteriosclerosis, Thrombosis, and Vascular Biology : 662 -666.
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida H., Dohi, H., Egusa, G., Hiro, T., Hirobe, K., Iida, M., Kihara, S., Kinoshita, M., Maruyama, C., Ohta, T., Okamura, T., Yamashita, S., Yokode, M. and Yokote, K., 2012. Diagnostic criteria of dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan – 2012 version. Journal of Atherosclerosis and Thrombosis 20: 655-660.
'Diagnostic criteria of dyslipidemia ' () 20 Journal of Atherosclerosis and Thrombosis : 655 -660.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 385 | 320 | 25 |
Full Text Views | 14 | 7 | 2 |
PDF Views & Downloads | 22 | 18 | 4 |
Low-density lipoprotein (LDL)-cholesterol, malondialdehyde-modified low-density lipoprotein (MDA-LDL), MDA-LDL/LDL-cholesterol in serum, and blood pressure are considered useful risk markers of cardiovascular diseases. This study aimed to examine whether a fermented milk containing Streptococcus thermophilus YIT 2001 (ST), which has high anti-oxidative activity, would benefit healthy and mildly hyper-LDL-cholesterolaemic adults via a randomised, double-blind, placebo-controlled trial. ST-fermented milk or non-fermented placebo milk (PC) was consumed once a day for 12 weeks by 29 and 30 subjects, respectively, with average serum LDL-cholesterol levels of about 140 mg/dl. Serum levels of LDL-cholesterol and MDA-LDL and blood pressure were analysed before (baseline) and after consumption. Comparisons of the responses between both groups were assessed using analysis of covariance (ANCOVA, with the baseline value as the covariate). ANCOVA demonstrated that the ST group had significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, systolic blood pressure (SBP), and diastolic blood pressure (DBP) compared with the PC group during the consumption period (P<0.05). Moreover, stratified analysis revealed that there were significant reductions in MDA-LDL, MDA-LDL/LDL-cholesterol, SBP, and DBP in the ST group compared with the PC group during the consumption period in subjects who had above median (65 U/l) levels of oxidative stress marker MDA-LDL at baseline (P<0.05), but not in subjects with levels below the median. These findings suggest that daily consumption of ST-fermented milk may be beneficial in healthy or mildly hyper-LDL cholesterolaemic subjects through reductions in risk marker values of oxidative stress and/or cardiovascular diseases. The benefits were particularly remarkable in subjects who had higher levels of MDA-LDL.
All Time | Past 365 days | Past 30 Days | |
---|---|---|---|
Abstract Views | 385 | 320 | 25 |
Full Text Views | 14 | 7 | 2 |
PDF Views & Downloads | 22 | 18 | 4 |